Login

Company Executives

Officer Age In this role 2025 pay Source
Sanjiv K. Patel, M.D. Also a director
President and CEO
Title from the Form 4 dated Oct 7, 2026
52 Not stated $4,646,454
Thomas Catinazzo
Chief Financial Officer
49 Since 2022
4 years
$1,568,613
Donald Bergstrom
President, R&D
Title from the Form 4 dated Oct 28, 2026
54 Not stated Not reported
Peter Rahmer
See remarks
Title from the Form 4 dated Oct 28, 2026
44 Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
9
serving now
Independent
8 of 9
stated in the proxy
Average tenure
5.8 years
from year joined
CEO also chairs the board
No
Alexis Borisy
Director Age On board Independent Other public boards 2025 pay Source
Alexis Borisy
54 2015
11 years
Independent None stated $410,499
Sanjiv K. Patel, M.D.
52 2017
9 years
Not independent None stated Paid as CEO
Douglas S. Ingram
63 2019
7 years
Independent Sarepta Therapeutics, Inc., Arrowhead Pharmaceuticals, Inc. $372,999
Claire Mazumdar, Ph.D.
36 2025
1 year
Independent Bicara Therapeutics, Inc. $999,999
Linda A. Hill, Ph.D.
69 2018
8 years
Independent None stated $375,499
Lonnel Coats
61 2025
1 year
Independent None stated $985,944
Mark Murcko, Ph.D.
66 2016
10 years
Independent None stated $378,923
Habib Joseph Dable
56 2025
1 year
Independent Day One Biopharmaceuticals, Inc., PepGen Inc., SpyGlass Pharma, Inc. $985,156
Sekar Kathiresan, M.D. Leaving at the meeting
54 2022
4 years
Independent None stated $362,999

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 28, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support